Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI

Direct oral anticoagulants (DOACs) represent an attractive alternative to low-molecular-weight heparins (LMWHs) for the long-term treatment of cancer-associated thrombosis (CT) since they avoid the burden of daily injections. Analyses in subgroups of cancer patients from large randomized trials sugg...

Full description

Bibliographic Details
Main Authors:	Isabelle Mahé, Ismaïl Elalamy, Grigoris T. Gerotziafas, Philippe Girard
Format:	Article
Language:	English
Published:	Georg Thieme Verlag KG 2019-07-01
Series:	TH Open
Subjects:	cancer-associated thrombosis direct oral anticoagulants low-molecular-weight heparins
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0039-1696659

Similar Items

Cancer thrombosis: Narrative review
by: Pritesh Naresh Munot, et al.
Published: (2020-01-01)

Erratum: Treatment of Cancer-Associated Thrombosis: Beyond HOKUSAI
by: Isabelle Mahé, et al.
Published: (2019-10-01)

Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis
by: Kaidireyahan Wumaier, et al.
Published: (2021-09-01)

Sinovenous Thrombosis: Anticoagulation Therapy
by: J Gordon Millichap
Published: (1998-12-01)

The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
by: Hanny Al-Samkari, et al.
Published: (2018-08-01)

Updates in Anticoagulation Therapy Monitoring
by: Hannah L. McRae, et al.
Published: (2021-03-01)

Cancer-Associated Thrombosis: A New Light on an Old Story
by: Sidrah Shah, et al.
Published: (2021-05-01)

Recent Advances in the Management of Cancer-Associated Thrombosis: New Hopes but New Challenges
by: Corinne Frere, et al.
Published: (2019-01-01)

Preventing Venous Thromboembolism in Ambulatory Patients with Cancer: A Narrative Review
by: Anne Rossel, et al.
Published: (2020-03-01)

Cancer-Associated Venous Thromboembolism: A Practical Review Beyond Low-Molecular-Weight Heparins
by: Alannah Smrke, et al.
Published: (2017-08-01)

Treatment of cancer-related thrombosis: from recommendations to real clinical practice
by: Oksana V Somonova, et al.
Published: (2019-03-01)

Feasibility of anticoagulation using low molecular-weight heparin during catheter-directed thrombolysis for lower extremity deep venous thrombosis
by: Yonghui Li, et al.
Published: (2021-01-01)

Comparative analysis of enoxaparin versus rivaroxaban in the treatment of cancer associated venous thromboembolism: experience from a tertiary care cancer centre
by: Anadil Faqah, et al.
Published: (2020-05-01)

Management of Cancer-Associated Thrombosis: An Evolving Area
by: Corinne Frere, et al.
Published: (2020-10-01)

Pharmacokinetics of low molecular weight heparins in thrombosis, complicate the treatment of children with cancer
by: V. V. Dmitriev, et al.
Published: (2021-04-01)

Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We Stand?
by: Frits I. Mulder, et al.
Published: (2020-02-01)

Deep vein thrombosis in bilateral lower extremities after hip fracture: a retrospective study of 463 patients
by: Zhang BF, et al.
Published: (2018-04-01)

How to manage new oral anticoagulants in case of surgery
by: Davide Imberti
Published: (2013-12-01)

Prevention of VTE in orthopedic surgery patients
by: Federico Spandonaro, et al.
Published: (2013-10-01)

ANTITHROMBOTIC THERAPY IN CANCER PATIENTS
by: A. V. Vorobev, et al.
Published: (2016-06-01)

Confusing combination of thrombocytopenia and thrombosis after heparin therapy in a patient with cardiac leiomyosarcoma; a nephrologist viewpoint
by: Ardalan Mohammad-Reza
Published: (2014-04-01)

Osteoporosis and antithrombotic therapy
by: N. V. Brailova, et al.
Published: (2021-06-01)

Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials
by: Florian Moik, et al.
Published: (2020-05-01)

Risk factors for deep vein thrombosis even using low-molecular-weight heparin after total knee arthroplasty
by: Joon Kyu Lee, et al.
Published: (2021-09-01)

Clinical and Pathophysiological Aspects of the Effect of Anticoagulants on Bone Tissue
by: O. D. Ostroumova, et al.
Published: (2020-07-01)

Direct acting oral anticoagulants versus low molecular weight heparin for primary thromboprophylaxis in cancer patients
by: Natalia Méndez, et al.
Published: (2021-05-01)

Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting
by: Harry Menon, et al.
Published: (2018-10-01)

Ewolucja leczenia przeciwzakrzepowego – od kleszcza i pijawki do tabletki
by: Wiesława Bednarek, et al.
Published: (2010-08-01)

Deep vein thrombosis: An experience of 25 years from north India
by: Sayyed Ehtesham Hussain Naqvi, et al.
Published: (2016-01-01)

Venous thrombosis in children, adolescents and young adults with acute lymphoblastic leukemia receiving chemotherapy in the Republic of Belarus
by: V. V. Dmitriev, et al.
Published: (2019-07-01)

Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2
by: Burak Pamukçu
Published: (2020-10-01)

Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill
by: Benjamin Brenner, et al.
Published: (2019-04-01)

Treatment and Prevention of Cancer-Associated Thrombosis in Frail Patients: Tailored Management
by: Florian Scotté, et al.
Published: (2019-01-01)

The Role of Direct Oral Anticoagulants in Cancer-Associated Thrombosis According to the Current Literature
by: Petroula Nana, et al.
Published: (2021-09-01)

Direct Oral Anticoagulants as Successful Treatment of Heparin-Induced Thrombocytopenia: A Parisian Retrospective Case Series
by: Julie Carré, et al.
Published: (2021-08-01)

Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented
by: Dominique Farge, et al.
Published: (2020-03-01)

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
by: Baumgarten, P., et al.
Published: (2022)

Management of deep-vein thrombosis in pregnancy
by: Nabnita Patnaik, et al.
Published: (2021-01-01)

Comparative Evaluation of Efficacy, Safety and Haemostatic Parameters of Enoxaparin and Fondaparinux in Unstable Coronary Artery Disease
by: Sanjay Shah, et al.
Published: (2014-01-01)

Asymptomatic “breakthrough” thrombosis and anticoagulant “failure”: Keep calm and carry on
by: Sven R. Olson, et al.
Published: (2019-07-01)

Cannot write session to /tmp/vufind_sessions/sess_qbtrq9ne783js08irqud1jljvb